Article
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
14 May 2019
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identified by genome-wide analyses. Mutations in major PDAC driver genes were associated with poor survival. By bioinformatics analysis, we identified protocadherins among the most frequently mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
